Hal Walsh, Brand Insights Contributor, CEO of SymmetryRx, LLC
Advertisement
Hal Walsh currently serves as the Chief Executive Officer of SymmetryRx, LLC.
As CEO, Hal provides vision, strategy, leadership, and resources to build web-based solutions to increase the reach of pharmaceutical manufacturers to healthcare providers and their patients.
Articles by Hal Walsh, Brand Insights Contributor, CEO of SymmetryRx, LLC
Advertisement
Latest Updated Articles
- Prescriber Access to Drug Samples in Virtual Environments
Published: March 15th 2021 | Updated:
- The NRx Crisis
Published: November 19th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novo Nordisk’s Bloomington Plant Receives FDA OAI Designation Following Contamination and Compliance Issues
2
United States Delays Tariffs on Singapore’s Pharma Exports Amid Ongoing Trade Negotiations
3
Pharma Pulse: FDA Approves One-Minute HIV Test, US Delays Pharma Tariffs, and CVS Acquires 600 Rite Aid Stores
4
Pharma Pulse: Kaiser Permanente Strike Escalates, Takeda Partners with Nabla Bio, and FDA Flags Novo Nordisk Bloomington Site
5
